Organoid technology as an emerging tool for gynecological oncology research
Kadi Lõhmussaar(Novo Nordisk Foundation)
Cited by 0
Related Papers
Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids
|Nature Communications|2020|120